Glucose-Responsive Sequential Generation of Hydrogen Peroxide and Nitric Oxide for Synergistic Cancer Starving-Like/Gas Therapy

Angew Chem Int Ed Engl. 2017 Jan 24;56(5):1229-1233. doi: 10.1002/anie.201610682. Epub 2016 Dec 9.

Abstract

Glucose is a key energy supplier and nutrient for tumor growth. Herein, inspired by the glucose oxidase (GOx)-assisted conversion of glucose into gluconic acid and toxic H2 O2 , a novel treatment paradigm of starving-like therapy is developed for significant tumor-killing effects, more effective than conventional starving therapy by only cutting off the energy supply. Furthermore, the generated acidic H2 O2 can oxidize l-Arginine (l-Arg) into NO for enhanced gas therapy. By using hollow mesoporous organosilica nanoparticle (HMON) as a biocompatible/biodegradable nanocarrier for the co-delivery of GOx and l-Arg, a novel glucose-responsive nanomedicine (l-Arg-HMON-GOx) has been for the first time constructed for synergistic cancer starving-like/gas therapy without the need of external excitation, which yields a remarkable H2 O2 -NO cooperative anticancer effect with minimal adverse effect.

Keywords: hydrogen peroxide; mesoporous nanomaterials; nitric oxide; synergistic therapy; ultrasound imaging.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Arginine / chemistry
  • Cell Line, Tumor
  • Cell Proliferation
  • Glucose / metabolism*
  • Glucose Oxidase / metabolism
  • Glucose Oxidase / therapeutic use
  • Humans
  • Hydrogen Peroxide / metabolism*
  • Nanomedicine
  • Nanoparticles / chemistry
  • Nanoparticles / therapeutic use
  • Neoplasms / metabolism
  • Neoplasms / pathology
  • Neoplasms / therapy
  • Nitric Oxide / metabolism*
  • Oxidation-Reduction
  • Porosity
  • Silicon Dioxide / chemistry

Substances

  • Nitric Oxide
  • Silicon Dioxide
  • Arginine
  • Hydrogen Peroxide
  • Glucose Oxidase
  • Glucose